Beximco Pharma, a leading drug maker in Bangladesh and a unit of business conglomerate Beximco Group, secured a $51.6 billion loan from Germany-based BHF-Bangk Aktiengesellshaft. A German export credit agency Euler Hermes will be the guarantor of the loan. Earlier, Bangladesh Investment Board approved Beximco Pharma’s proposal to raise funds to utilize in new plant as well as machinery purchasing. The interest rate of that loan will be lower than that of local rate. It is only 2.25 percent. According to Beximco Pharma, the loan will be drawn down in four tranches and repayment will be made over five years in 10 semi-annual installments. The total interest bearing debt of the company was Tk.480 crore and debt-to equity ratio was 23.5 percent as of September 30 th in 2014. The cost of debt was 16.1 percent on average while debt-to-equity averaged 22.7 percent in the previous four years. That is why analysts think that this loan at a single digit rate will have immense impact